[Are cells of the immune system of the lamina propria of the stomach the targets of anti-ulcer drugs?].
Jacquot
S
S
D000328:Adult; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000235:genetics; D011954:Receptors, Dopamine / Q000235:genetics; D011970:Receptors, Histamine H2 / Q000235:genetics*; D011976:Receptors, Muscarinic / Q000235:genetics*
D000897:Anti-Ulcer Agents; D012333:RNA, Messenger; D011949:Receptors, Cholecystokinin; D011954:Receptors, Dopamine; D011970:Receptors, Histamine H2; D011976:Receptors, Muscarinic
Les cellules du système immunitaire de la lamina propria de l'estomac sont-elles la cible des médicaments anti-ulcéreux?